Royal Bank of Canada’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $941K | Sell |
28,452
-216
| -0.8% | -$9.14K | ﹤0.01% | 3666 |
|
|
2025
Q4 | $1.33M | Sell |
28,668
-23,024
| -45% | -$963K | ﹤0.01% | 3441 |
|
|
2025
Q3 | $1.81M | Buy |
51,692
+468
| +0.9% | +$16.3K | ﹤0.01% | 3484 |
|
|
2025
Q2 | $1.51M | Sell |
51,224
-7,386
| -13% | -$211K | ﹤0.01% | 3539 |
|
|
2025
Q1 | $1.75M | Sell |
58,610
-37,171
| -39% | -$1.14M | ﹤0.01% | 3043 |
|
|
2024
Q4 | $2.74M | Buy |
95,781
+25,275
| +36% | +$836K | ﹤0.01% | 2795 |
|
|
2024
Q3 | $2.72M | Buy |
70,506
+25,438
| +56% | +$907K | ﹤0.01% | 2766 |
|
|
2024
Q2 | $1.45M | Sell |
45,068
-4,367
| -9% | -$151K | ﹤0.01% | 3148 |
|
|
2024
Q1 | $1.92M | Sell |
49,435
-1,537
| -3% | -$53.8K | ﹤0.01% | 2952 |
|
|
2023
Q4 | $1.57M | Buy |
50,972
+7,722
| +18% | +$193K | ﹤0.01% | 3269 |
|
|
2023
Q3 | $967K | Buy |
43,250
+2,519
| +6% | +$57.5K | ﹤0.01% | 3473 |
|
|
2023
Q2 | $875K | Buy |
40,731
+9,309
| +30% | +$211K | ﹤0.01% | 3482 |
|
|
2023
Q1 | $753K | Buy |
31,422
+9,881
| +46% | +$262K | ﹤0.01% | 3544 |
|
|
2022
Q4 | $500K | Buy |
21,541
+2,917
| +16% | +$58.8K | ﹤0.01% | 4107 |
|
|
2022
Q3 | $299K | Buy |
18,624
+3,329
| +22% | +$58.7K | ﹤0.01% | 4438 |
|
|
2022
Q2 | $270K | Buy |
15,295
+594
| +4% | +$9.99K | ﹤0.01% | 4563 |
|
|
2022
Q1 | $299K | Buy |
14,701
+8,206
| +126% | +$155K | ﹤0.01% | 4726 |
|
|
2021
Q4 | $121K | Buy |
6,495
+2,848
| +78% | +$55.5K | ﹤0.01% | 5786 |
|
|
2021
Q3 | $72K | Buy |
3,647
+537
| +17% | +$11.6K | ﹤0.01% | 5937 |
|
|
2021
Q2 | $74K | Buy |
3,110
+2,410
| +344% | +$55.7K | ﹤0.01% | 5775 |
|
|
2021
Q1 | $17K | Sell |
700
-640
| -48% | -$15.2K | ﹤0.01% | 6509 |
|
|
2020
Q4 | $27K | Sell |
1,340
-960
| -42% | -$18.7K | ﹤0.01% | 5923 |
|
|
2020
Q3 | $48K | Sell |
2,300
-5,975
| -72% | -$108K | ﹤0.01% | 5353 |
|
|
2020
Q2 | $145K | Sell |
8,275
-4,744
| -36% | -$92.9K | ﹤0.01% | 4629 |
|
|
2020
Q1 | $213K | Sell |
13,019
-9,397
| -42% | -$194K | ﹤0.01% | 4280 |
|
|
2019
Q4 | $462K | Buy |
22,416
+966
| +5% | +$16.1K | ﹤0.01% | 4044 |
|
|
2019
Q3 | $246K | Buy |
21,450
+4,175
| +24% | +$47.7K | ﹤0.01% | 4315 |
|
|
2019
Q2 | $227K | Buy |
17,275
+4,350
| +34% | +$58.2K | ﹤0.01% | 4404 |
|
|
2019
Q1 | $196K | Sell |
12,925
-8,751
| -40% | -$140K | ﹤0.01% | 4366 |
|
|
2018
Q4 | $373K | Sell |
21,676
-4,988
| -19% | -$85.3K | ﹤0.01% | 3919 |
|
|
2018
Q3 | $393K | Buy |
26,664
+9,738
| +58% | +$173K | ﹤0.01% | 4055 |
|
|
2018
Q2 | $403K | Sell |
16,926
-11,312
| -40% | -$278K | ﹤0.01% | 3943 |
|
|
2018
Q1 | $721K | Buy |
28,238
+2,437
| +9% | +$58.1K | ﹤0.01% | 3416 |
|
|
2017
Q4 | $476K | Sell |
25,801
-2,628
| -9% | -$37.6K | ﹤0.01% | 3822 |
|
|
2017
Q3 | $298K | Sell |
28,429
-710
| -2% | -$7.83K | ﹤0.01% | 4207 |
|
|
2017
Q2 | $365K | Buy |
29,139
+3,285
| +13% | +$32.5K | ﹤0.01% | 3909 |
|
|
2017
Q1 | $261K | Buy |
25,854
+5,784
| +29% | +$86K | ﹤0.01% | 4159 |
|
|
2016
Q4 | $312K | Buy |
20,070
+4,720
| +31% | +$78.4K | ﹤0.01% | 4166 |
|
|
2016
Q3 | $296K | Buy |
15,350
+3,750
| +32% | +$44.5K | ﹤0.01% | 4149 |
|
|
2016
Q2 | $137K | Buy |
11,600
+300
| +3% | +$4.96K | ﹤0.01% | 4632 |
|
|
2016
Q1 | $205K | Buy |
11,300
+10,036
| +794% | +$182K | ﹤0.01% | 4357 |
|
|
2015
Q4 | $35K | Buy |
1,264
+965
| +323% | +$20.3K | ﹤0.01% | 5482 |
|
|
2015
Q3 | $7K | Sell |
299
-153
| -34% | -$2.77K | ﹤0.01% | 6036 |
|
|
2015
Q2 | $8K | Buy |
+452
| New | +$7.82K | ﹤0.01% | 6122 |
|
Other funds holding COLL
EAM
VCM
